🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Polycystic Kidney Disease

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Early PKD Observational Cohort Study NCT02936791n/a3 sites📍 Chicago📍 Kansas City📍 Kansas City University of Kansas Medical Center HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life NCT05373264Phase 325 sites📍 Graz📍 Innsbruck📍 Antwerp University Medical Center Groningen · Tests: Hydrochlorothiazide 25 mg, Placebo RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY NCT07535385n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Polycystic Kidney Disease Data Repository NCT00792155n/a1 site📍 New York The Rogosin Institute Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease NCT07260071n/a1 site📍 London King's College London Managing Depressive Symptoms in ADPKD NCT07745920NA1 site📍 Rochester Mayo Clinic · Tests: Mayo Clinic-Approved Education, Digital Neuropathy, Capacity Coaching Analysis of Patients With Autosomal Dominant Polycystic Kidney NCT06759142n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives NCT07792408Phase 11 site📍 Montreal Vertex Pharmaceuticals Incorporated · Tests: VX-407, LNG/EE, NGM/EE, NET/EE, DRSP/EE ADPKD Patient Registry NCT04039061n/a1 site📍 Kansas City PKD Foundation ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT06902558Phase 291 sites📍 Birmingham📍 Huntington Park📍 Los Angeles Calico Life Sciences LLC · Tests: ABBV-CLS-628, Placebo Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment NCT06618638NA9 sites📍 Anyang-si📍 Seoul📍 Busan Seoul National University Hospital · Tests: Shared decision making model, Usual Care Imaging Assessments of ARPKD Kidney Disease Progression NCT07201025n/a2 sites📍 Cleveland📍 Philadelphia The Cleveland Clinic Genetics in the Progression of Nephropathies NCT06416761n/a1 site📍 Milan Ospedale San Raffaele · Tests: genetic polymorphisms Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT06800651Phase 21 site📍 Beijing Jemincare · Tests: JMKX003142 will be administered orally, Plcacebo Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study NCT04338048n/a4 sites📍 Washington D.C.📍 Rochester📍 New Hyde Park Children's Hospital of Philadelphia Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) NCT04939935Phase 349 sites📍 Gosford📍 Sydney📍 Sydney The University of Queensland · Tests: Metformin XR, Control Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease NCT06291116Phase 24 sites📍 Amiens📍 Caen📍 Lille University Hospital, Rouen · Tests: standard care + rotigotine at 4 mg/24h for 24 months., standard care for 24 months. Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease NCT07454174NA1 site📍 Cleveland Richard Fatica · Tests: Ren-Nu and KetoCitra STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease NCT07280585Phase 330 sites📍 Feldkirch📍 Innsbruck📍 Stuttgart University of Cologne · Tests: Dapagliflozin 10 mg, Matching Placebo Well-Formulated Ketogenic Diet Polycystic Kidney Disease NCT06325644NA1 site📍 Columbus Ohio State University · Tests: Ketogenic Diet, Ketone/Glucose Monitoring, CGM/CKM, Blood Draw, Body Composition The German ADPKD Tolvaptan Treatment Registry NCT02497521n/a12 sites📍 Müllheim📍 Würzburg📍 Hanover University of Cologne Kidney Sodium Functional Imaging NCT05014178n/a1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Sodium-23 MRI Bempedoic Acid Therapy for Polycystic Kidney Disease NCT07282821Phase 23 sites📍 Baltimore📍 Boston📍 Burlington Kenneth Hallows · Tests: Bempedoic Acid 180 MG Oral Tablet, Placebo Capsule(s) Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases NCT05996731NA1 site📍 Ranica Mario Negri Institute for Pharmacological Research · Tests: Skin biopsy Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose NCT07868926Phase 11 site📍 Lincoln Vertex Pharmaceuticals Incorporated · Tests: 14C-VX-407 National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders NCT06147414n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sample A Prospective Observational Study of Foam Sclerotherapy . NCT04111692n/a1 site📍 Rochester Mayo Clinic Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT04344769n/a1 site📍 Rochester Mayo Clinic
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy